apomorphine has been researched along with thiazoles in 37 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (13.51) | 18.7374 |
1990's | 23 (62.16) | 18.2507 |
2000's | 9 (24.32) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Canevari, R; Gressier, H; Petitjean, M; Poignant, JC; Regnier, G | 1 |
Dunn, RW; Errico, CL; Hrib, NJ; Huger, FP; Jurcak, JG | 1 |
Bergmeier, S; Caprathe, BW; Heffner, TG; Humblet, CC; Jaen, JC; Meltzer, LT; Pugsley, TA; Tecle, H; Wise, LD | 1 |
Abou-Gharbia, M; Andree, T; Haskins, JT; Moyer, JA; Patel, U; Schiehser, G; Webb, M | 1 |
Benavides, J; Camelin, JC; Flamand, F; Gueremy, C; Le Fur, G; Legrand, JJ; Mitrani, N; Uzan, A | 1 |
Kobinger, W; Pichler, L | 1 |
Bergstrom, DA; Gonzalez, AM; Huang, KX; Kreiss, DS; Sibley, DR; Walters, JR | 1 |
Guanowsky, V; Howard, HR; Lebel, LA; Lowe, JA; McLean, S; Schmidt, AW; Schulz, DW; Seeger, TF; Seymour, PA; Zorn, SH | 1 |
Ikeda, K; Ishibashi, T; Ishida, K; Kato, T; Nakamura, M; Ohno, Y | 1 |
Lin, MY; Walters, DE | 1 |
Carlsson, A; Huff, RM; Kling-Petersen, T; Svensson, K; Waters, N | 1 |
Burgher, KL; Conway, PG; Hartman, HB; Hrib, NJ; Jurcak, JG; Kerman, LL; Roehr, JE; Woods, AT | 1 |
Cooper, BR; Navas, F; Norman, MH; Rigdon, GC | 1 |
Caprathe, BW; Christoffersen, CL; Corbin, AE; Jaen, JC; Meltzer, LT; Ninteman, FW; Pugsley, TA; Serpa, KA; Shih, YH; Whetzel, SZ | 1 |
Gueudet, C; Gully, D; Le Fur, G; Santucci, V; Soubrie, P; Thurneyssen, O | 1 |
Arnone, M; Gonalons, N; Gueudet, C; Gully, D; Heaulme, M; Keane, P; Le Fur, G; Poncelet, M; Santucci, V; Thurneyssen, O | 1 |
Ewing, FE; Furman, JS; Howard, HR; Jackson, E; Johnson, C; Lowe, JA; Maloney, PR; Morrone, J; Newman, ME; Robinson, GL; Schmidt, AW; Seeger, TF; Seymour, PA; Zorn, SH | 1 |
Hall, WR; Navas, F; Norman, MH; Rigdon, GC | 1 |
Bregna, DE; Burgher, KL; Corbett, R; Hartman, HB; Hrib, NJ; Jurcak, JG; Kafka, S; Kerman, LL; Kongsamut, S; Roehr, JE; Szewczak, MR; Woods-Kettelberger, AT | 1 |
Cooper, BR; Cox, RF; Durcan, MJ; Gengo, PJ; Jones-Humble, SA; Lyerly, D; Morgan, PF; Norton, RM; Russell, AV; Tang, FL; Wang, CM; Watson, MJ | 1 |
Barnéoud, P; Boireau, A; Doble, A; Dubédat, P; Mazadier, M; Miquet, JM; Parmentier, S | 1 |
Navas, F; Norman, MH; Rigdon, GC; Thompson, JB | 1 |
Fici, GJ; Sethy, VH; VonVoigtlander, PF; Wu, H | 1 |
Chaki, S; Kawashima, N; Kumagai, T; Nagamine, M; Nakazato, A; Ogawa, S; Okuyama, S; Suzuki, Y; Tomisawa, K; Yamaguchi, K | 1 |
Brouillet, E; Guyot, MC; Hantraye, P; Mary, V; Palfi, S; Peschanski, M; Riche, D; Stutzmann, JM; Wahl, F | 1 |
Lange, KW | 1 |
Factor, SA | 1 |
Felicio, LF; Ferreira, FS; Nasello, AG; Sassatani, AS; Tieppo, CA | 1 |
Sternon, J; Supiot, F; Zegers de Beyl, D | 1 |
Jankovic, J; Le, WD | 1 |
Aggarwal, A; Balakhaneh, D; Callaway, DJ; Hartley, DM; Lashuel, HA; Teichberg, S | 1 |
Albin, RL; Desmond, TJ; Frey, KA; Kemmerer, ES; Kilbourn, MR | 1 |
DHAWAN, BN; GUPTA, GP; SAXENA, PN | 1 |
Goetz, CG; Poewe, W; Rascol, O; Sampaio, C | 1 |
Kääriäinen, TM; Kekki, H; Lecklin, A; Lehtonen, S; Männistö, PT; Nenonen, T; Ossola, B; Piltonen, M; Raasmaja, A | 1 |
Bilici, N; Gören, B; Korfali, E; Mimbay, Z; Oğul, E; Zarifoğlu, M | 1 |
Antus, S; Berényi, S; Lehmann, J; Mueller, FK; Sipos, A | 1 |
4 review(s) available for apomorphine and thiazoles
Article | Year |
---|---|
Clinical pharmacology of dopamine agonists in Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Apomorphine; Benzothiazoles; Cabergoline; Dopamine Agonists; Ergolines; Ergot Alkaloids; Humans; Indoles; Neuroprotective Agents; Parkinson Disease; Pramipexole; Thiazoles | 1998 |
Dopamine agonists.
Topics: Apomorphine; Benzothiazoles; Bromocriptine; Dopamine Agonists; Humans; Indoles; Parkinson Disease; Pergolide; Pramipexole; Randomized Controlled Trials as Topic; Receptors, Dopamine; Thiazoles; Treatment Outcome | 1999 |
Are dopamine receptor agonists neuroprotective in Parkinson's disease?
Topics: Animals; Antiparkinson Agents; Apomorphine; Benzothiazoles; Bromocriptine; Cell Culture Techniques; Clinical Trials as Topic; Dopamine Agonists; Humans; Indoles; Models, Animal; Neuroprotective Agents; Parkinson Disease; Pergolide; Pramipexole; Substantia Nigra; Thiazoles | 2001 |
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
Topics: Amantadine; Antiparkinson Agents; Apomorphine; Benzophenones; Benzothiazoles; Bromocriptine; Cabergoline; Catechol O-Methyltransferase Inhibitors; Deep Brain Stimulation; Dihydroergocryptine; Ergolines; Fetal Tissue Transplantation; Globus Pallidus; Humans; Indans; Indoles; Levodopa; Lisuride; Mesencephalon; Monoamine Oxidase Inhibitors; Neurosurgical Procedures; Nitrophenols; Parkinson Disease; Pergolide; Piribedil; Pramipexole; Selegiline; Thiazoles; Tolcapone | 2005 |
33 other study(ies) available for apomorphine and thiazoles
Article | Year |
---|---|
A new central direct dopaminergic stimulant: 1-(Coumaran-5-yl methyl)-4-(2-thiazolyl) piperazine hydrochloride (S 3608).
Topics: Animals; Apomorphine; Behavior, Animal; Benzofurans; Catatonia; Corpus Striatum; Drug Interactions; Ergolines; Humans; Hydroxydopamines; Male; Morphine; Piperazines; Rats; Stereotyped Behavior; Substantia Nigra; Thiazoles; Yohimbine | 1975 |
Synthesis and biological evaluation of a series of substituted N-alkoxyimides and -amides as potential atypical antipsychotic agents.
Topics: Amides; Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Catalepsy; Chemical Phenomena; Chemistry; Drug Evaluation, Preclinical; Imides; Male; Mice; Molecular Structure; Motor Activity; Phthalimides; Piperazines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Serotonin; Self Stimulation; Social Behavior; Spiro Compounds; Stereotyped Behavior; Thiazoles | 1991 |
4-(1,2,5,6-Tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines: a novel class of compounds with central dopamine agonist properties.
Topics: Animals; Apomorphine; Chemical Phenomena; Chemistry; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dopamine Agents; Haloperidol; Male; Molecular Conformation; Molecular Structure; Motor Activity; Neurons; Pyridines; Rats; Receptors, Dopamine; Receptors, Dopamine D2; Structure-Activity Relationship; Substantia Nigra; Thermodynamics; Thiazoles | 1990 |
Synthesis and structure-activity relationship of substituted tetrahydro- and hexahydro-1,2-benzisothiazol-3-one 1,1-dioxides and thiadiazinones: potential anxiolytic agents.
Topics: Animals; Anti-Anxiety Agents; Apomorphine; Avoidance Learning; Cyclic S-Oxides; In Vitro Techniques; Male; Rats; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Serotonin; Stereotyped Behavior; Structure-Activity Relationship; Thiadiazines; Thiazines; Thiazoles | 1989 |
2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission--II. Biochemical properties.
Topics: Acetylcholine; Amino Acids; Animals; Anticonvulsants; Apomorphine; Cerebellum; Chlordiazepoxide; Cyclic GMP; Diazepam; gamma-Aminobutyric Acid; Harmaline; In Vitro Techniques; Injections, Intraventricular; Isoniazid; Male; Rats; Rats, Inbred Strains; Riluzole; Synaptic Transmission; Thiazoles | 1985 |
Modulation of motor activity by alpha 1- and alpha 2-adrenoceptor stimulation in mice.
Topics: Adrenergic alpha-Agonists; Animals; Apomorphine; Azepines; Clonidine; Exploratory Behavior; Male; Mice; Motor Activity; Thiazoles | 1981 |
Dopamine receptor agonist potencies for inhibition of cell firing correlate with dopamine D3 receptor binding affinities.
Topics: Aminoquinolines; Animals; Apomorphine; Azepines; Benzothiazoles; Binding, Competitive; CHO Cells; Cricetinae; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Imidazoles; Male; Neurons; Phenethylamines; Piperidines; Pramipexole; Quinolines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Structure-Activity Relationship; Substantia Nigra; Tetrahydronaphthalenes; Thiazoles; Thiophenes; Transfection | 1995 |
Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
Topics: Adenylyl Cyclases; Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Biogenic Monoamines; Brain; Catalepsy; Cattle; CHO Cells; Choroid Plexus; Cricetinae; Cyclic AMP; Dopamine Antagonists; Guinea Pigs; Humans; Male; Mice; Mice, Inbred Strains; Motor Activity; Neurotransmitter Uptake Inhibitors; Piperazines; Quipazine; Rats; Receptors, Adrenergic; Receptors, Dopamine; Receptors, Serotonin; Serotonin Antagonists; Swine; Thiazoles | 1995 |
Effects of chronic treatments with SM-9018, a potential atypical neuroleptic, on behavioral dopaminergic and serotonergic sensitivities in rats.
Topics: 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Dopamine; Haloperidol; Indoles; Isoindoles; Male; Motor Activity; Posture; Rats; Rats, Sprague-Dawley; Serotonin; Stereotyped Behavior; Thiazoles | 1995 |
Dopamine D2 autoreceptors in rats are behaviorally functional at 21 but not 10 days of age.
Topics: Aging; Aminoquinolines; Animals; Apomorphine; Azepines; Behavior, Animal; Benzothiazoles; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Male; Motor Activity; Piperidines; Pramipexole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Thiazoles | 1994 |
Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors.
Topics: Analysis of Variance; Animals; Apomorphine; Benzothiazoles; CHO Cells; Cricetinae; Cricetulus; Dihydroxyphenylalanine; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Male; Microdialysis; Mitogens; Motor Activity; Piperidines; Pramipexole; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Tetrahydronaphthalenes; Thiazoles; Transfection | 1994 |
Benzisoxazole- and benzisothiazole-3-carboxamides as potential atypical antipsychotic agents.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Isoxazoles; Male; Mice; Rats; Rats, Wistar; Stereotyped Behavior; Structure-Activity Relationship; Thiazoles | 1994 |
Cyclic benzamides as mixed dopamine D2/serotonin 5-HT2 receptor antagonists: potential atypical antipsychotic agents.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Binding, Competitive; Catalepsy; Corpus Striatum; Cyclization; Dopamine D2 Receptor Antagonists; Frontal Lobe; Hippocampus; Indoles; Isoindoles; Male; Mice; Molecular Structure; Motor Activity; Phthalazines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Serotonin; Serotonin Antagonists; Structure-Activity Relationship; Thiazoles | 1994 |
Pharmacological profile of the dopamine partial agonist, (+/-)-PD 128483 and its enantiomers.
Topics: 4-Butyrolactone; Aminoquinolines; Amphetamine; Animals; Apomorphine; Avoidance Learning; Behavior, Animal; Cebus; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Extrapyramidal Tracts; Male; Mice; Motor Activity; Neurons; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Saimiri; Serotonin; Stereoisomerism; Stereotyped Behavior; Stimulation, Chemical; Thiazoles | 1993 |
The CCKA receptor antagonist SR 27897 differentially influences the activity of A9 and A10 dopaminergic neurons in the rat.
Topics: Animals; Apomorphine; Benzodiazepinones; Devazepide; Dopamine; Indoleacetic Acids; Male; Mesencephalon; Neurons; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Sincalide; Thiazoles | 1994 |
Neurobehavioural effects of SR 27897, a selective cholecystokinin type A (CCK-A) receptor antagonist.
Topics: Animals; Apomorphine; Brain; Cyclic GMP; Dose-Response Relationship, Drug; Female; Indoleacetic Acids; Male; Mice; Motor Activity; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Cholecystokinin; Thiazoles | 1993 |
3-Benzisothiazolylpiperazine derivatives as potential atypical antipsychotic agents.
Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Brain; Catalepsy; Clozapine; Dopamine; Drug Design; Humans; Molecular Structure; Phosphatidylinositols; Piperazines; Prazosin; Rats; Receptors, Adrenergic; Receptors, Dopamine; Serotonin Antagonists; Thiazoles | 1996 |
Structure-activity relationships of a series of substituted benzamides: potent D2/5-HT2 antagonists and 5-HT1a agonists as neuroleptic agents.
Topics: Animals; Antipsychotic Agents; Apomorphine; Mice; Molecular Structure; Motor Activity; Piperazines; Receptors, Dopamine D2; Receptors, Serotonin; Serotonin Receptor Agonists; Structure-Activity Relationship; Thiazoles | 1996 |
Structure-activity relationships of a series of novel (piperazinylbutyl)thiazolidinone antipsychotic agents related to 3-[4-[4-(6-fluorobenzo[b]thien-3-yl)-1-piperazinyl]butyl]-2,5,5- trimethyl-4-thiazolidinone maleate.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Binding, Competitive; Cell Line; CHO Cells; Cricetinae; Humans; Male; Molecular Structure; Motor Activity; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D4; Receptors, Serotonin; Spiperone; Spiro Compounds; Stereotyped Behavior; Structure-Activity Relationship; Thiazoles; Thiazolidines | 1996 |
Preclinical neurochemical and electrophysiological profile of 1192U90, a potential antipsychotic.
Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Biogenic Amines; Brain; Clozapine; Male; Neurons; Piperazines; Radioligand Assay; Rats; Thiazoles | 1996 |
Neuroprotective effects of riluzole on a model of Parkinson's disease in the rat.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amphetamine; Animals; Apomorphine; Brain Chemistry; Central Nervous System Stimulants; Conditioning, Operant; Dopamine Agonists; Female; Male; Neuroprotective Agents; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Inbred Strains; Riluzole; Stereotyped Behavior; Substantia Nigra; Sympatholytics; Thiazoles | 1996 |
Synthesis and evaluation of heterocyclic carboxamides as potential antipsychotic agents.
Topics: Animals; Antipsychotic Agents; Apomorphine; Benzamides; Clozapine; Heterocyclic Compounds; Magnetic Resonance Spectroscopy; Mice; Molecular Structure; Piperazines; Raclopride; Receptors, Dopamine; Receptors, Serotonin; Risperidone; Salicylamides; Thiazoles | 1996 |
D1 dopamine receptor activity of anti-parkinsonian drugs.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antiparkinson Agents; Apomorphine; Benzazepines; Benzothiazoles; Bromocriptine; Cells, Cultured; Cerebellum; Clozapine; Cyclic AMP; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Pergolide; Pramipexole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Tetrahydronaphthalenes; Thiazoles | 1997 |
The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats.
Topics: Animals; Antipsychotic Agents; Apomorphine; Clozapine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Male; Maze Learning; Methamphetamine; Motor Activity; Pyrrolidines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D4; Receptors, Serotonin; Serotonin Antagonists; Thiazoles | 1997 |
Riluzole reduces incidence of abnormal movements but not striatal cell death in a primate model of progressive striatal degeneration.
Topics: Acetylcholinesterase; Animals; Antiparkinson Agents; Apomorphine; Caudate Nucleus; Corpus Striatum; Movement Disorders; Nerve Degeneration; Neurons; Neuroprotective Agents; Neurotoxins; Nitro Compounds; Papio; Parkinson Disease, Secondary; Propionates; Putamen; Riluzole; Thiazoles | 1997 |
Opposite modulation of apomorphine- or amphetamine-induced stereotypy by antagonists of CCK receptors.
Topics: Amphetamine; Animals; Apomorphine; Benzodiazepinones; Dopamine; Indoleacetic Acids; Male; Phenylurea Compounds; Rats; Rats, Wistar; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Stereotyped Behavior; Thiazoles | 2000 |
[Dopaminergic agonists in the treatment of Parkinson's disease].
Topics: Aged; Antiparkinson Agents; Apomorphine; Benzothiazoles; Biological Availability; Bromocriptine; Catechols; Dopamine Agonists; Drug Combinations; Drug Hypersensitivity; Humans; Hypotension, Orthostatic; Indoles; Levodopa; Metabolic Clearance Rate; Nitriles; Parkinson Disease; Pergolide; Pramipexole; Selegiline; Thiazoles | 2000 |
New class of inhibitors of amyloid-beta fibril formation. Implications for the mechanism of pathogenesis in Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Apomorphine; Benzothiazoles; Fluorescent Dyes; Humans; Hydroxylation; Kinetics; Microscopy, Electron; Models, Biological; Protein Structure, Quaternary; Thiazoles | 2002 |
Treatment effects on nigrostriatal projection integrity in partial 6-OHDA lesions: comparison of L-DOPA and pramipexole.
Topics: Amphetamine; Animals; Antiparkinson Agents; Apomorphine; Autoradiography; Behavior, Animal; Benzothiazoles; Binding, Competitive; Corpus Striatum; Disease Models, Animal; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Motor Activity; Neuropeptides; Oxidopamine; Parkinsonian Disorders; Pramipexole; Rats; Rats, Sprague-Dawley; Substantia Nigra; Thiazoles; Treatment Outcome; Tritium; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2003 |
Antagonism of apomorphine-induced pecking in pigeons.
Topics: Animals; Antiemetics; Apnea; Apomorphine; Central Nervous System; Columbidae; Diphenhydramine; Emetics; Lysergic Acid Diethylamide; Promethazine; Psychopharmacology; Radiography; Scopolamine; Thiazoles; Vomiting | 1961 |
Lack of robust protective effect of quercetin in two types of 6-hydroxydopamine-induced parkinsonian models in rats and dopaminergic cell cultures.
Topics: Amphetamine; Animals; Antioxidants; Apomorphine; Behavior, Animal; Cell Line, Tumor; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Humans; L-Lactate Dehydrogenase; Male; Motor Activity; Neuroblastoma; Oxidopamine; Parkinson Disease; Quercetin; Rats; Rats, Wistar; Substantia Nigra; Tetrazolium Salts; Thiazoles; Tyrosine 3-Monooxygenase | 2008 |
Investigation of neuroprotective effects of cyclooxygenase inhibitors in the 6-hydroxydopamine induced rat Parkinson model.
Topics: Amphetamines; Animals; Antiparkinson Agents; Apomorphine; Aspirin; Behavior, Animal; Cyclooxygenase Inhibitors; Disease Models, Animal; Female; Immunohistochemistry; Meloxicam; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar; Sympatholytics; Thiazines; Thiazoles | 2009 |
Synthesis and pharmacological evaluation of thiazole and isothiazole derived apomorphines.
Topics: Apomorphine; Binding Sites; Calcium Signaling; Cell Line; Computer Simulation; Computer-Aided Design; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Design; Humans; Isomerism; Models, Molecular; Molecular Structure; Protein Conformation; Radioligand Assay; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Thiazoles; Transfection | 2009 |